|
RNPS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.07509995245425E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.10860000027635E-07 |
| Normal-vs-Stage2 |
2.035900E-03 |
| Normal-vs-Stage3 |
3.91259999954485E-07 |
| Normal-vs-Stage4 |
4.421700E-03 |
| Stage1-vs-Stage2 |
6.918600E-01 |
| Stage1-vs-Stage3 |
3.177000E-03 |
| Stage1-vs-Stage4 |
1.196150E-02 |
| Stage2-vs-Stage3 |
4.821000E-03 |
| Stage2-vs-Stage4 |
3.291500E-02 |
| Stage3-vs-Stage4 |
9.645600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00450003870378E-09 |
| Normal-vs-AfricanAmerican |
7.56210000000257E-05 |
| Normal-vs-Asian |
3.174000E-01 |
| Caucasian-vs-AfricanAmerican |
5.760500E-02 |
| Caucasian-vs-Asian |
4.869600E-01 |
| AfricanAmerican-vs-Asian |
9.543000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.40809999613379E-09 |
| Normal-vs-Female |
1.52409999953917E-07 |
| Male-vs-Female |
9.557800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.31100000000529E-05 |
| Normal-vs-Extreme_Weight |
6.21700002589876E-09 |
| Normal-vs-Obese |
5.28439999536445E-08 |
| Normal-vs-Extreme_Obese |
6.848200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.158400E-01 |
| Normal_Weight-vs-Obese |
1.253550E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.114200E-01 |
| Extreme_Weight-vs-Obese |
5.376000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.194200E-01 |
| Obese-vs-Extreme_Obese |
1.247400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.19340000104273E-08 |
| Normal-vs-Age(41-60Yrs) |
6.56220000561092E-09 |
| Normal-vs-Age(61-80Yrs) |
6.3993000010143E-08 |
| Normal-vs-Age(81-100Yrs) |
9.165900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.817900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.535600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.65770000000776E-05 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.369800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.393000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.757670E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.13799969447825E-10 |
| Normal-VS-Type2 PRCC |
7.515100E-03 |
| Normal-VS-KIRP CIMP |
1.784420E-04 |
| Normal-VS-Unclassified PRCC |
1.388170E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.88585999999491E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.72934000000069E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.163000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.86830000546013E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
2.943700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.752700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.423880E-03 |
| Normal-vs-N1 |
8.29470000018873E-07 |
| Normal-vs-N2 |
3.990600E-04 |
| N0-vs-N1 |
2.774000E-04 |
| N0-vs-N2 |
1.463600E-01 |
| N1-vs-N2 |
6.729800E-01 |
|
|
